Anthem Biosciences Limited (ANTHEM) — Financial Results

· NSE Neutral

Anthem Biosciences Limited announced that its designated insiders are barred from trading company shares from July 1, 2026 until 48 hours after the board meeting approving the June 30, 2026 quarter results, as required under SEBI insider trading regulations.

📄 View Original Announcement (PDF)

About Anthem Biosciences Limited (ANTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹43,999.05 Cr P/E: 109.4

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

📊 More ANTHEM filings

See all ANTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day